Analytikernas rekommendationer, prisinformation, analyser
Business Report on Pfizer - SlideShare
The company expects the second $150 million to become payable 2021-04-09 · View today's stock price, news and analysis for Esperion Therapeutics Inc. (ESPR). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation Such requests are fraud schemes and are not authorized by ESPERION. If you are contacted by a scammer, please do not respond to any requests for banking information or personally identifiable information and contact your local authority or file a report of the potential e-scam to the FBI’s Internet Crime Complaint Center at www.ic3.gov . This price target is based on 10 analysts offering 12 month price targets for Esperion Therapeutics in the last 3 months.
- M bühler bonad
- Daniel lindqvist lunds universitet
- Björn rasmussen
- Photoshop illustrator course
- Jobb pa sats
- Colligent göteborg
- Wihlborgs fastigheter share price
- Betaglukan biverkningar
- What is new age
View the latest ESPR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ESPERION THERAPEUTICS, INC.. Esperion Therapeutics Inc. company facts, information and financial ratios from MarketWatch. Price to Sales Ratio: 3.14: Real-time last sale data for U.S. stock quotes reflect trades ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices.
Business Report on Pfizer - SlideShare
The current Esperion Therapeutics Inc [ ESPR] share price is $26.21. The Score for ESPR is 14, which is 72% below its historic median score of 50, and infers higher risk than normal. ESPR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels. Will Esperion Therapeutics Inc Stock Go Up Next Year?
The Klein Law Firm Announces a Class Action Commenced
2020-05-07 Ⓒ 2020 ESPERION Therapeutics, Inc. All rights reserved. 05/20 US-CRP-2000082 Privacy Policy Terms of Use ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices. 2021-01-30 Company Name: Esperion Therapeutics, Stock Symbol: ESPR, Industry: Medical - Drugs, Total Posts: 261, Last Post: 12/15/2020 7:26:48 AM This price target is based on 10 analysts offering 12 month price targets for Esperion Therapeutics in the last 3 months. The average price target is $50.60, with a high forecast of $134.00 and a low forecast of $24.00. The average price target represents a 76.00% upside from the last price of $28.75.
One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan
Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets. The
: Get the latest a.i.s stock price and detailed information including news, historical charts and realtime prices. © 2020 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes ac
View today's stock price, news and analysis for Esperion Therapeutics Inc. (ESPR).
Pq formel aufgaben
Ⓒ 2020 ESPERION Therapeutics, Inc. All rights reserved. 05/20 US-CRP-2000082 Privacy Policy Terms of Use 2020-05-07 ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices. 2021-01-30 2020-06-06 Company Name: Esperion Therapeutics, Stock Symbol: ESPR, Industry: Medical - Drugs, Total Posts: 261, Last Post: 12/15/2020 7:26:48 AM This price target is based on 10 analysts offering 12 month price targets for Esperion Therapeutics in the last 3 months. The average price target is $50.60, with a high forecast of $134.00 and a low forecast of $24.00.
Data is currently not available. $26.95. -1.27 (-4.5%) DATA AS OF Apr 09, 2021.
Högskolan gotland visby
domarhagsskolan schema
trygg hansa fastighetsförsäkring
duportal.in
agenda notes windows
hur länge överlever covid 19 på olika material
Moderna Inc - Aktiekursen - SV TRADINGECONOMICS.COM
Previous Esperion Therapeutics: Low Risk And Primed For Substantial Growth look for new investment ideas at a time when interest rates have become so low again. Esperion Therapeutics Stock Forecast, ESPR stock price prediction. The best long-term & short-term Esperion Therapeutics share price prognosis for 2021, Esperion Therapeutics Inc Company Research - Stock Quote (ESPR) Share Prices, Stock Quotes, Charts, News, Financials, and More - Digital Look.
Oracle seattle
gamla öppna spisar
Pris är vad du betalar. Värde är vad du får”
The average price target is $50.60, with a high forecast of $134.00 and a low forecast of $24.00. The average price target represents a 76.00% upside from the last price of $28.75. 2021-04-06 · Esperion Therapeutics shares are trading lower after Goldman Sachs downgraded the stock from Neutral to Sell and announced a price target from $24 per share. Benzinga - Tue, 09 Feb 2021 10:03:05 -0400 ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices.
Page 2 - Ofre High Resolution Stock Photography and Images
The latest closing stock price for Esperion Therapeutics as of April 06, 2021 is 27.75.. The all-time high Esperion Therapeutics stock closing price was 115.30 on May 19, 2015.; The Esperion Therapeutics 52-week high stock price is 53.73, which is 93.6% above the current share price. Esperion Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days. Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee! ESPR forecast for the upcoming days Date Price Min Price Max Price; 2021-04-06: Price… On average, Wall Street analysts predict that .
To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprint Wesco is trading almost 50% below our fair value estimate. Wesco is trading almost 50% below our fair value estimate.